AI Trends

Trending story

English translation is being prepared.

1 reports1 story updatesUpdated Nov 18 23:31

Understand this story

Story summary

The English summary is being updated. See the reporting timeline below.

Latest development · Report

Jitai Technology Begins Preparations for A-Share Listing as Commercialization of AI Drug Delivery Accelerates

Developments

1 confirmed developments

  1. English translation is being prepared.

    Source:English text is being prepared.

Reports and discussion timeline

Browse reports and discussion by time. Their evidence levels remain distinct.

Nov 18

  1. Securities Times

    Jitai Technology Begins Preparations for A-Share Listing as Commercialization of AI Drug Delivery Accelerates

    Jitai Technology has begun preparations for an A-share listing and engaged a pre-listing advisory firm, but has yet to finalize a supporting plan or submit a formal application. Revenue in the first half of this year reached RMB 154 million, up 13,399% year on year, while its adjusted net loss narrowed by 56.4% to RMB 51 million. The company has also recently entered into partnerships with Eli Lilly, JOINN Laboratories and Hengrui Pharma to advance the commercialization of LNP and mRNA drugs and the AiTEM platform.

Related stories

  1. Related storiesGuangdong Provincial People's Government Issues the "15th Five-Year Plan for Digital Guangdong Construction"
  2. Related storiesTencent Holdings Releases Third-Quarter 2026 Financial Report
  3. Related storiesChemical Leak Occurs at SpaceXAI Data Center
  4. Related storiesNVIDIA Announces Third Quarter Fiscal 2027 Results, Jensen Huang Will Not Return as CEO